MAP3K2 and cardiac hypertrophy: Furthermore, animal models of disease suggest that ablation of MEKK2 expression blocks hypertension-induced cardiac hypertrophy and breast xenograft tumor metastasis, leading to considerable interest in MEKK2 as a therapeutic target.